Latest papers

Oncolytic viruses: now interviewing for the all-star game.

Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging.

Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virus.

The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins.

Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma.

Viral oncolysis that targets Raf-1 signaling control of nuclear transport.

Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma.

Oncolytic viruses: an approved product on the horizon?

A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors.

Efficient fluorescence-based imaging methods for quantitating infectivity and oncolytic efficacy of Newcastle disease virus.

Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma.

Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours.

Current issues and future directions of oncolytic adenoviruses.

Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers.

In silico evolutionary dynamics of tumour virotherapy.

An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.

The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin.

Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.

HSF1 overexpression enhances oncolytic effect of replicative adenovirus.

Improved killing of human high-grade glioma cells by combining ionizing radiation with oncolytic parvovirus H-1 infection.